as on December 9, 2025 at 10:41 pm IST
Day's Low
Day's High
-0.04%
Downside
0.75%
Upside
52 Week's Low
52 Week's High
7.38%
Downside
24.80%
Upside
Check Sanofi market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$120.9B
EPS (TTM)
4.5717
Dividend Yield
3.62%
Quarterly Earnings Growth YOY
0.02%
PE Ratio (TTM)
16.24
Industry PE ratio
19.200384615384614
PEG Ratio
0.773
EBITDA
12.3B
Revenue (TTM)
45.9B
Profit Margin
19.84%
Return On Equity TTM
8.84%
Track how Sanofi P/E has moved over time to understand its valuation trends.
Sanofi in the last 5 years
Lowest (8.47x)
December 31, 2023
Today (16.24x)
December 9, 2025
Industry (19.20x)
December 9, 2025
Highest (14.50x)
June 30, 2021
Today’s Price to Earnings Ratio: 16.24x
Compare market cap, revenue, PE, and other key metrics of Sanofi with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
|---|---|---|---|---|---|
| BUY | $120.9B | -2.36% | 16.24 | 19.84% | |
| BUY | $905.7B | 531.39% | 49.5 | 30.99% | |
| BUY | $399.6B | 105.32% | 172.58 | 4.00% | |
| BUY | $486.5B | 31.69% | 19.49 | 27.26% | |
| BUY | $249.1B | 18.52% | 13.19 | 29.63% |
The Sanofi stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Sanofi investment value today
Current value as on today
₹1,05,325
Returns
₹5,325
(+5.33%)
Returns from Sanofi Stock
Dollar Returns*
₹5,862 (+5.86%)
Based on 31 analysts
74.19%
Buy
22.58%
Hold
3.23%
Sell
Based on 31 analysts, 74.19% of analysts recommend a 'BUY' rating for Sanofi. Average target price of $60.13
Get share price movements and forecasts by analysts on Sanofi.
What analysts predicted
19.89%UPSIDE
Target Price
$60.13
Current Price
$48.17
Analyzed by
31 Analysts
Target
$60.13
Sanofi target price $60.13, a slight upside of 19.89% compared to current price of $48.17. According to 31 analysts rating.
Investment in Sanofi Shares on INDmoney has grown by 3.33% over the past 30 days, indicating increased transactional activity.
Time period: to
Change:3.33% versus previous 30 day period
Search interest for Sanofi Stock has increased by 19% in the last 30 days, reflecting an upward trend in search activity.
Time period: to
Change:19% versus previous 30 day period
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
Today's Timeline - 28 November
Fri, 12:49 PM
-Sanofi receives EU approval for Dupixent to treat chronic spontaneous urticaria in patients aged 12 and above.
Sat, 02:31 AM
-Sanofi invests 50 million euros in Le Trait site to boost Dupixent production amid rising demand.
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Revenue Rich
![]()
Sanofi has shown strong revenue growth over the last four quarters, increasing from $7.63 billion to $13.17 billion. This represents an average quarterly increase of 15.9%.
Against Peers
![]()
In the last 3 years, Eli Lilly And Company has given 14.7% return, outperforming this stock by 10.0%
Against Peers
![]()
In the last 1 year, Johnson & Johnson has given 34.8% return, outperforming this stock by 34.8%
Profit Down
![]()
Sanofi's net profit has decreased for the last two quarters, falling from $3.94 billion to $2.80 billion. This represents an average decline of 28.9% per quarter.
Price Dip
![]()
In the last 7 days, SNY stock has moved down by -2.8%
| Organisation | Sanofi |
| Headquarters | 46, avenue de la Grande Armée, Paris, France, 75017 |
| Industry | Health Technology |
| CEO | Mr. Paul Hudson |
| E-voting on shares | Click here to vote |
Name | Title |
|---|---|
Mr. Paul Hudson | CEO & Director |
Mr. Roy Papatheodorou | Executive VP & General Counsel |
Mr. Pierre Chancel | Senior Vice President of Global Diabetes and Senior Vice President of Global Marketing |
Mr. Olivier Charmeil | Executive Vice President of General Medicines |
Fabrizio Gaudi | Head of Austrian, German & Swiss Operations |
Mr. François-Xavier Roger | Executive VP & CFO |
Ms. Madeleine Roach | Executive VP & Head of Business Operations |
Mr. Thomas Kudsk Larsen | Head of Investor Relations |
Ms. Natalie Bickford | Executive VP & Chief People Officer |
Mr. Felix Lauscher | Head of IR North America & Asia |
Sanofi share price today is $48.17 as on . Sanofi share today touched a day high of $48.53 and a low of $48.19.
Sanofi share touched a 52 week high of $60.12 on and a 52 week low of $44.62 on . Sanofi stock price today i.e. is trending at $48.17,which is 19.87% down from its 52 week high and 7.96% up from its 52 week low.
Sanofi market capitalisation is $0.12T as on .
Indian investors can start investing in Sanofi (SNY) shares with as little as ₹89.831 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹898.31 in Sanofi stock (as per the Rupee-Dollar exchange rate as on ).
Based on Sanofi share’s latest price of $48.17 as on December 9, 2025 at 10:41 pm IST, you will get 0.2076 shares of Sanofi. Learn more about
fractional shares .
Sanofi stock has given -2.36% share price returns and 22.24% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?